Crispr Infuses First Human in Landmark Gene-Editing Study

Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.

from NDTV Gadgets - Latest https://ift.tt/2XjoJ5n

Comments

Popular posts from this blog

WWDC 2024 to Take Place From June 10 to June 14: All You Need to Know

Transform Your Everyday: Galaxy AI Enhances the Samsung Galaxy S23 FE - Grab the Limited Time Offer!